X @Forbes
Forbes·2026-01-29 22:32
A 'Holy Grail' Sleep Apnea Pill Could Be On The Market Next YearThe disease affects as many as 80 million in the U.S. alone. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.Read more: https://t.co/Vjs2cq7po3 https://t.co/qQ2jOoAUGK ...